Gillette India Limited has announced a board meeting scheduled for May 27, 2026, to review key financial matters for the concluded financial year. The announcement was made through an official communication to stock exchanges on March 27, 2026.

Board Meeting Agenda

The board meeting has been convened under Regulation 29 of the Securities Exchange Board of India (Listing Obligation and Disclosure Requirements) Regulations, 2015. The meeting will address two primary matters:

Regulatory Compliance

The company has fulfilled its disclosure obligations by informing both major stock exchanges about the upcoming board meeting. The notification was sent to:

• BSE Limited - Corporate Relations Department (Scrip Code: 507815)
• National Stock Exchange of India Limited - Listing Department (NSE Symbol: GILLETTE)

The communication was digitally signed by Company Secretary Flavia Machado on March 27, 2026, ensuring proper authentication and regulatory compliance.

Company Information

Gillette India Limited operates under CIN L28931MH1984PLC267130, with its registered office located at P&G Plaza, Cardinal Gracias Road, Chakala, Andheri (E), Mumbai 400099. The company maintains its corporate website at in.pg.com and can be reached at (91-22) 6958 6000.

The upcoming board meeting represents a standard corporate governance practice, allowing directors to review the company's financial performance for the concluded financial year and make appropriate decisions regarding shareholder returns through dividend distribution.

Gillette India Limited has successfully obtained approval from the Rajasthan State Pollution Control Board (RSPCB) for the renewal of Consent to Operate (CTO) for its Bhiwadi manufacturing facility. The approval was granted on March 19, 2026, marking a positive resolution to the regulatory challenges that began with the initial refusal in February.

Regulatory Approval Secured

Following the submission of fresh applications after discussions with the RSPCB, the company has now received the necessary regulatory clearance. The approval covers the renewal of Consent to Operate (CTO) for the company's manufacturing facility at Bhiwadi. This development was communicated through an official intimation filed under Regulation 30 of SEBI Listing Regulations on March 19, 2026.

Resolution Timeline

The regulatory journey began with the RSPCB's initial refusal to renew operational permits communicated on February 18, 2026. Following discussions with the regulatory authority, Gillette India submitted fresh applications for renewal of CTO and authorization under Hazardous Waste (Management and Transboundary) Rules on March 18, 2026. The swift approval within one day demonstrates effective regulatory engagement and compliance.

Operational Continuity Maintained

Throughout the regulatory process, Gillette India confirmed that there has been no impact on ongoing operations at the Bhiwadi plant. The facility continued to function normally while the fresh applications were being processed by the RSPCB. This operational continuity reflects the company's effective interim arrangements and regulatory compliance measures.

Market Communication and Compliance

Gillette India has maintained transparency with stock exchanges by promptly informing both NSE and BSE about the developments. The company's commitment to keeping investors informed about material developments reflects adherence to regulatory requirements under SEBI Listing Regulations. This transparent communication approach helps maintain investor confidence during regulatory processes and demonstrates effective corporate governance practices.